Immuno-Oncology in Glioblastoma

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".

Deadline for manuscript submissions: closed (20 December 2022) | Viewed by 302

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pathology, School of Medicine, Virgen Macarena University Hospital, University of Seville, 41009 Seville, Spain
Interests: immunooncology; cancer; pathology; molecular pathology; gliomas; neuropathology; oncogenesis; breast cancer; biomarkers

Special Issue Information

Dear Colleagues,

Glioblastoma multiforme (GBM) is the most common primary brain cancer that affects children and adults against which we do not have effective therapy. Recently, immunotherapy has emerged as an alternative to traditional chemo-radiotherapeutic treatments. It is reasonable that there is a group of patients affected by GBM who have factors that favor the immune response and that would be good candidates for treatment with immunotherapy. To identify this group of patients, it is necessary to evaluate and quantify key parameters with high precision and reproducibility. Tumor-infiltrating lymphocytes (named TILs) and factors related to the degree of tumor immunogenicity including the tumor mutational burden, the instability of microsatellites and the molecular subtype of GBM have been postulated as relevant biomarkers. We have postulated that the microglia/macrophage infiltrate could be an especially relevant immunosuppressive mechanism in GBM. For this sake, we have quantified TILs and tumor-associated macrophages (TAMs) in GBM and analyzed their prognostic impact. In conclusion, we propose the use of digital image analysis to quantify TILs in order to obtain more precise values for clinic–pathological correlations. In this way, it can be shown that the expression of M2 macrophage in GBM is significantly associated with worse prognosis. In addition, the higher values of CD8 lymphocytes in GBM are also associated with poorer prognosis in GBM, which could be explained as a reflection of an anergic state of effector cells. We hypothesize that M2 macrophage recruitment and PD1-PDL1 expression may be a defensive strategy upregulated by GBM in response to TILs.

Prof. Dr. Miguel A. Idoate
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • glioblastoma
  • M2 macrophages
  • prognosis
  • biomarker
  • quantification
  • digital image analysis
  • PD1-PDL1 expression
  • T effector cells

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop